Literature DB >> 30385383

Intracardiac pulsed field ablation: Proof of feasibility in a chronic porcine model.

Mark T Stewart1, David E Haines2, Atul Verma3, Nicole Kirchhof4, Noah Barka4, Erin Grassl4, Brian Howard1.   

Abstract

BACKGROUND: Radiofrequency (RF) has become an accepted energy source for myocardial ablation but may result in discontinuous lesions and nontargeted tissue injury. We examined the feasibility and safety of lesion formation using high-amplitude, bipolar pulsed electric fields delivered from a multielectrode array catheter.
OBJECTIVE: The purpose of this study was to compare duty-cycled radiofrequency ablation (RFA) to pulsed field ablation (PFA) in terms of acute electrical effects, 2-week lesion formation, and injury to nontargeted tissues.
METHODS: Intracardiac ablations were performed in 6 pigs using a circular pulmonary vein ablation catheter. The energy source for ablation delivery was randomized to deliver either PFA or RFA to 3 atrial endocardial sites. Bipolar pace capture and electrogram amplitude measurements were recorded at each site. Histopathology and necropsies were performed after 2 weeks.
RESULTS: The circular pulmonary vein ablation catheter was used to deliver pulsed electric fields to produce cardiac lesions without skeletal muscle stimulation. Evaluating all ablations in each site, electrogram amplitudes were reduced to <0.5 mV in 67.5% of PFA vs 27.0% of RFA deliveries (P <.001). Bipolar cardiac capture was lost after 100% vs 92.0% of PFA vs RFA (P = .005). At 2 weeks, PFA resulted in consistent transmural and homogeneous replacement fibrosis devoid of lingering myocyte "sequesters." RFA lesions showed a stronger inflammatory response extending to the epicardial fat, arterial injury, and thrombosis. Neither PFA nor RFA lesions showed endocardial thrombus.
CONCLUSION: Intracardiac PFA can be feasibly delivered from a circular catheter to create fibrotic lesions that have acute electrical effects, without injury to nontargeted tissue.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Cardiac ablation; Irreversible electroporation; Pathology; Pulmonary vein isolation; Pulsed electric field; Radiofrequency; Transmurality

Year:  2018        PMID: 30385383     DOI: 10.1016/j.hrthm.2018.10.030

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  20 in total

Review 1.  Pulsed Field Ablation: a Novel Therapeutic Tool for Catheter-Based Treatment of Atrial Fibrillation.

Authors:  Andrew E Darby
Journal:  Curr Cardiol Rep       Date:  2022-05-24       Impact factor: 3.955

2.  Characterization of Phrenic Nerve Response to Pulsed Field Ablation.

Authors:  Brian Howard; David E Haines; Atul Verma; Nicole Kirchhof; Noah Barka; Birce Onal; Mark T Stewart; Daniel C Sigg
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-06-01

3.  Taking the "pulse" of pulsed-field ablation: Real-world experience.

Authors:  Tina Baykaner; Muhammad Fazal; Atul Verma
Journal:  J Cardiovasc Electrophysiol       Date:  2022-01-12       Impact factor: 2.942

Review 4.  Catheter ablation for atrial fibrillation: current indications and evolving technologies.

Authors:  Ramanathan Parameswaran; Ahmed M Al-Kaisey; Jonathan M Kalman
Journal:  Nat Rev Cardiol       Date:  2020-10-13       Impact factor: 32.419

5.  Circular Multielectrode Pulsed Field Ablation Catheter Lasso Pulsed Field Ablation: Lesion Characteristics, Durability, and Effect on Neighboring Structures.

Authors:  Hagai Yavin; Erez Brem; Israel Zilberman; Ayelet Shapira-Daniels; Keshava Datta; Assaf Govari; Andres Altmann; Ante Anic; Oussama Wazni; Elad Anter
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-01-08

6.  Short microsecond pulses achieve homogeneous electroporation of elongated biological cells irrespective of their orientation in electric field.

Authors:  Janja Dermol-Černe; Tina Batista Napotnik; Matej Reberšek; Damijan Miklavčič
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

7.  Endocardial ventricular pulsed field ablation: a proof-of-concept preclinical evaluation.

Authors:  Jacob S Koruth; Kenji Kuroki; Jin Iwasawa; Raju Viswanathan; Richard Brose; Eric D Buck; Elina Donskoy; Srinivas R Dukkipati; Vivek Y Reddy
Journal:  Europace       Date:  2020-03-01       Impact factor: 5.214

8.  Feasibility of selective cardiac ventricular electroporation.

Authors:  Alan Sugrue; Vaibhav R Vaidya; Christopher Livia; Deepak Padmanabhan; Anas Abudan; Ameesh Isath; Tyra Witt; Christopher V DeSimone; Paul Stalboerger; Suraj Kapa; Samuel J Asirvatham; Christopher J McLeod
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

9.  Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation.

Authors:  Jacob Koruth; Kenji Kuroki; Jin Iwasawa; Yoshinari Enomoto; Raju Viswanathan; Richard Brose; Eric D Buck; Molly Speltz; Srinivas R Dukkipati; Vivek Y Reddy
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-12-12

10.  Reduction in Pulmonary Vein Stenosis and Collateral Damage With Pulsed Field Ablation Compared With Radiofrequency Ablation in a Canine Model.

Authors:  Brian Howard; David E Haines; Atul Verma; Douglas Packer; Nicole Kirchhof; Noah Barka; Birce Onal; Steve Fraasch; Damijan Miklavčič; Mark T Stewart
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.